Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul-Aug;29(4):243-247.
doi: 10.1097/PPO.0000000000000669.

The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma

Benjamin S Rosen  1 , Neil Vaishampayan, Yue Cao, Michelle L Mierzwa
Affiliations
Review

The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma

Benjamin S Rosen et al. Cancer J. 2023 Jul-Aug.

Abstract

In this article, as part of this special issue on biomarkers of early response, we review the current evidence to support the use of positron emission tomography (PET) imaging during chemoradiation therapy to inform biologically adaptive radiotherapy for head and neck squamous cell carcinoma. We review literature covering this topic spanning nearly 3 decades, including the use of various radiotracers and discoveries of novel predictive PET biomarkers. Through understanding how observational trials have informed current interventional clinical trials, we hope that this review will encourage researchers and clinicians to incorporate PET response criteria in new trial designs to advance biologically optimized radiotherapy.

PubMed Disclaimer

References

    1. Ramón y Cajal S, Sesé M, Capdevila C, et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl). 2020;98:161–177.
    1. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood. 2007;110:3507–3516.
    1. El-Galaly TC, Villa D, Gormsen LC, et al. FDG-PET/CT in the management of lymphomas: current status and future directions. J Intern Med. 2018;284:358–376.
    1. Al-Ibraheem A, Anwer F, Juweid ME, et al. Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's lymphoma. Sci Rep. 2022;12:17702.
    1. Cremonesi M, Gilardi L, Ferrari ME, et al. Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of non–small cell lung cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review. Eur J Nucl Med Mol Imaging. 2017;44:1915–1927.

MeSH terms

LinkOut - more resources